Indication
Non-transfusion-dependent Thalassemia
2 clinical trials
3 products
Clinical trial
A Randomised, Single-blind, Placebo-controlled, Phase 1, Single-ascending and Multiple-dose Study in Adult Subjects With Alpha/Beta-thalassaemia and Very Low- and Low-risk Myelodysplastic Syndrome to Investigate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Response of SLN124.Status: Completed, Estimated PCD: 2023-05-23
Product
SLN124Product
PlaceboClinical trial
A Phase 2a, Double-blind, Randomised, Placebo-controlled, Parallel Group, Multicentre Study on Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Multiple Doses of VIT-2763 in Subjects With Non-transfusion Dependent β-thalassaemiaStatus: Completed, Estimated PCD: 2021-10-11
Product
VIT-2763